TELA
TELA
NASDAQ · Health Care

Tela Bio Inc

$0.63
+0.01 (+1.68%)
As of Apr 1, 3:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
121.50M
Net Income
-66,343,440
Gross Margin
67.1%
Profit Margin
-54.6%
Rev Growth
+33.0%
D/E Ratio
1.45
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.1% 67.1% 28.2% 28.2%
Operating Margin -49.2% -44.3% 18.2% 16.6%
Profit Margin -54.6% -51.9% 17.0% 16.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 121.50M 91.36M 7.47M 7.60M
Gross Profit 81.50M 61.28M 2.11M 2.15M
Operating Income -59,813,844 -40,478,577 1.36M 1.26M
Net Income -66,343,440 -44,897,432 1.27M 1.28M
Gross Margin 67.1% 67.1% 28.2% 28.2%
Operating Margin -49.2% -44.3% 18.2% 16.6%
Profit Margin -54.6% -51.9% 17.0% 16.9%
Rev Growth +33.0% +33.0% +18.1% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 9.82M 9.82M 9.64M 8.55M
Total Equity 6.79M 6.79M 26.51M 24.38M
D/E Ratio 1.45 1.45 0.36 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -56,215,625 -40,157,037 2.01M 2.00M
Free Cash Flow 1.14M 1.46M